UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Discover various ways to increase your cash back earnings. Enhance your savings potential with these effective strategies.
24,319 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
AI excitement has investors chasing the next big thing. Yet a cautionary line attributed to Sam Altman still echoes i...
Starting with $1,000 doesn't mean you have to settle for small gains. This guide lays out a clear framework to find t...
Nvidia is poised to report fiscal Q1 2027 results as traders assess whether it can sustain a 75% gross margin amid re...
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
When headlines shout about quantum computing stock plummeting, it can feel like a nerve-wracking moment for investors...
NIO reports its first-ever quarterly profit, but shares fall while Tesla leads a modest rally, illustrating the two-s...
A notable price dip in SpaceX shares has investors wondering if this is a turning point. This guide explains how to a...
As volatility remains a theme, smart investors are looking for growth stocks first half opportunities with real catal...
Quantum dreams meet market drama as Rigetti and peers grab headlines. This guide breaks down why rigetti computing st...
A sharp global copper crunch boosts Freeport-McMoRan as the leading domestic copper king. Investors eye FCX for cash ...
Investors are watching for 2026 policy shifts as the Fed weighs inflation, growth, and job data. Learn what could mov...